2009•Xiandai shengwu yixue jinzhanRequires access

A Clinical Study of Three-dimensional Conformal Radiotherapy with Temozolomide in Treatment of Postoperative Malignant Glinoma

XU Yan-hua

Open publisher page 0 citations

Abstract

Objective:To study the efficacy and security of three-dimensional conformal radiotherapy concomitant with temozolomide in patients with postoperative malignant glinoma.Methods:Eleven patients with pathologically confirmed malignant glinoma were treated by 3D-CRT after operation with a dose of 50-68Gy and concomitant temozolomide chemotherapy from Mar.2003 to Mar.2006.Results:The overall response rates were 81.8%,including six(54.5%) patients with complete responses,three(27.3%) patients with partial responses,one(9.1%) patients with stable disease and one(9.1%) patients with progressive disease.One,two and three years suvival rates were 63.6%,27.3% and 18.2%,respectively.Conclusions:Three-dimensional conformal radiotherapy concomitant with temozolomide is effective,good tolerance and safety in the treatment of postoperative malignant glinoma.

About this research paper

What this paper is about

Objective:To study the efficacy and security of three-dimensional conformal radiotherapy concomitant with temozolomide in patients with postoperative malignant glinoma.Methods:Eleven patients with pathologically confirmed malignant glinoma were treated by 3D-CRT after operation with a dose of 50-68Gy and concomitant temozolomide chemotherapy from Mar.2003 to Mar.2006.Results:The overall response rates were 81.8%,including six(54.5%) patients with complete responses,three(27.3%) patients with partial responses,one(9.1%) patients with stable disease and one(9.1%) patients with progressive disease.One,two and three years suvival rates were 63.6%,27.3% and 18.2%,respectively.Conclusions:Three-dimensional conformal radiotherapy concomitant with temozolomide is effective,good tolerance and safety in the treatment of postoperative malignant glinoma.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective:To study the efficacy and security of three-dimensional conformal radiotherapy concomitant with temozolomide in patients with postoperative malignant glinoma.Methods:Eleven patients with pathologically confirmed malignant glinoma were treated by 3D-CRT after operation with a dose of 50-68Gy and concomitant temozolomide chemotherapy from Mar.2003 to Mar.2006.Results:The overall response rates were 81.8%,including six(54.5%) patients with complete responses,three(27.3%) patients with partial responses,one(9.1%) patients with stable disease and one(9.1%) patients with progressive disease.One,two and three years suvival rates were 63.6%,27.3% and 18.2%,respectively.Conclusions:Three-dimensional conformal radiotherapy concomitant with temozolomide is effective,good tolerance and safety in the treatment of postoperative malignant glinoma.

Key concepts: Temozolomide, Concomitant, Medicine, Radiation therapy, Chemotherapy, Complete response, Internal medicine, Oncology

Related papers

Back to paper searchBrowse research topicsOriginal source
A Clinical Study of Three-dimensional Conformal Radiotherapy with Temozolomide in Treatment of Postoperative Malignant Glinoma — Research Paper | ScholarLens